Historical Valuation
Jin Medical International Ltd (ZJYL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Jin Medical International Ltd (ZJYL) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.25
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Jin Medical International Ltd (ZJYL) has a current Price-to-Book (P/B) ratio of 1.26. Compared to its 3-year average P/B ratio of 10.94 , the current P/B ratio is approximately -88.46% higher. Relative to its 5-year average P/B ratio of 10.94, the current P/B ratio is about -88.46% higher. Jin Medical International Ltd (ZJYL) has a Forward Free Cash Flow (FCF) yield of approximately -2.29%. Compared to its 3-year average FCF yield of 0.89%, the current FCF yield is approximately -357.77% lower. Relative to its 5-year average FCF yield of 0.89% , the current FCF yield is about -357.77% lower.
P/B
Median3y
10.94
Median5y
10.94
FCF Yield
Median3y
0.89
Median5y
0.89
Competitors Valuation Multiple
AI Analysis for ZJYL
The average P/S ratio for ZJYL competitors is 1.99, providing a benchmark for relative valuation. Jin Medical International Ltd Corp (ZJYL.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for ZJYL
1Y
3Y
5Y
Market capitalization of ZJYL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ZJYL in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ZJYL currently overvalued or undervalued?
Jin Medical International Ltd (ZJYL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Jin Medical International Ltd (ZJYL) is between to according to relative valuation methord.
What is Jin Medical International Ltd (ZJYL) fair value?
ZJYL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Jin Medical International Ltd (ZJYL) is between to according to relative valuation methord.
How does ZJYL's valuation metrics compare to the industry average?
The average P/S ratio for ZJYL's competitors is 1.99, providing a benchmark for relative valuation. Jin Medical International Ltd Corp (ZJYL) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Jin Medical International Ltd (ZJYL) as of Jan 10 2026?
As of Jan 10 2026, Jin Medical International Ltd (ZJYL) has a P/B ratio of 1.26. This indicates that the market values ZJYL at 1.26 times its book value.
What is the current FCF Yield for Jin Medical International Ltd (ZJYL) as of Jan 10 2026?
As of Jan 10 2026, Jin Medical International Ltd (ZJYL) has a FCF Yield of -2.29%. This means that for every dollar of Jin Medical International Ltd’s market capitalization, the company generates -2.29 cents in free cash flow.
What is the current Forward P/E ratio for Jin Medical International Ltd (ZJYL) as of Jan 10 2026?
As of Jan 10 2026, Jin Medical International Ltd (ZJYL) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Jin Medical International Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Jin Medical International Ltd (ZJYL) as of Jan 10 2026?
As of Jan 10 2026, Jin Medical International Ltd (ZJYL) has a Forward P/S ratio of 0.00. This means the market is valuing ZJYL at $0.00 for every dollar of expected revenue over the next 12 months.